Biogen's Alzheimer's drug lowers toxic protein, but results were mixed - Reuters
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQZjkxUXJSY1ZCREl0RGZWaDJ0OUhoU1J5d3I3ZFpXQURiTUYtQnFEWVkweHJZMmVYU1R1dVBUY01FQ2U3SVlKZEVyQnBFS2ZrNVcwR0lKUFFoU0FyTDEtU01zTHNKM01WdHBMTnlpNDZkVXdIQVM2TUtnaUVqaU1kSVV2Z3pqSFZLMm9Ydmh1TmtJRE5ORnJVSnZkQjhHeFJkZWEwYTlBd0U4UlFYN3psbThxaXJ3VmxsVVB5QjhuQ0JzQXI3UDdmdGZPNDRGSVFh?oc=5" target="_blank">Biogen's Alzheimer's drug lowers toxic protein, but results were mixed</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMPrader-Willi experts flag safety risks linked to Neurocrine's rare disease drug - Reuters
Prader-Willi experts flag safety risks linked to Neurocrine's rare disease drug Reuters
August 12, 2026 at 04:25 PMCerebras slumps as mixed quarterly results test AI growth narrative - Reuters
Cerebras slumps as mixed quarterly results test AI growth narrative Reuters
August 13, 2026 at 12:17 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PM